EZH2型
生物
甲基化
组蛋白甲基化
表观遗传学
组蛋白甲基转移酶
癌症研究
组蛋白H3
甲基转移酶
组蛋白
癌变
细胞生物学
DNA甲基化
癌症
生物化学
遗传学
基因表达
基因
作者
Lili Gao,Wenbin Yu,Peng Song,Qing Li
出处
期刊:Recent Patents on Anti-cancer Drug Discovery
[Bentham Science]
日期:2022-08-01
卷期号:17 (3): 231-243
被引量:3
标识
DOI:10.2174/1574892816666211202160041
摘要
(su(var)-3-9,enhancer-of-zeste,trithorax) domain-containing protein 7/9 (SET7/9) is a member of the protein lysine methyltransferases (PLMTs or PKMTs) family. It contains a SET domain. Recent studies demonstrate that SET7/9 methylates both lysine 4 of histone 3 (H3-K4) and lysine(s) of non-histone proteins, including transcription factors, tumor suppressors, and membrane-associated receptors.This article mainly reviews the non-histone methylation effects of SET7/9 and its functions in tumorigenesis and development.PubMed was screened for this information.SET7/9 plays a key regulatory role in various biological processes such as cell proliferation, transcription regulation, cell cycle, protein stability, cardiac morphogenesis, and development. In addition, SET7/9 is involved in the pathogenesis of hair loss, breast cancer progression, human carotid plaque atherosclerosis, chronic kidney disease, diabetes, obesity, ovarian cancer, prostate cancer, hepatocellular carcinoma, and pulmonary fibrosis.SET7/9 is an important methyltransferase, which can catalyze the methylation of a variety of proteins. Its substrates are closely related to the occurrence and development of tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI